FDA Women's Health Highlights: April e-Update

April 2014 www.fda.gov/womens Message from the Director During April, there is increased focus on health issues thanks to observances for National Public Health Week and Minority Health Month. I hope you will look to FDA for resources to support your women's health activities throughout the month. In this update, we feature resources for diverse groups of women: college students, women of color, researchers and pregnant women. Check out one of the links in this update and share the health tips, meeting announcements, and safety alerts with other women in your networks. Marsha Henderson Assistant Commissioner for Women's Health FDA Women's Health Highlights New College Women's Health Webpage OWH launched a new webpage to connect college aged women to FDA health information. The page includes links to general health and beauty resources on topics such as sleep problems, e-cigarettes, contact lens care, and safe medication use. The new online resource is an extension of OWH's national college campaign that has partnered with over 160 colleges and universities to distribute women's health information. Visit the college women's health webpage. OWH Symposium on Sex Differences At the annual meeting for the Organization for the Study of Sex Differences, OWH is chairing a symposium on April 25 on Sex Differences in Drug and Device Development. The symposium will feature presentations on sex differences in drugs and devices approved by FDA, modeling the female musculoskeletal system, and sex-based development of endovascular treatment. View the conference agenda and other meeting information. Learn more about FDA research, training, and policies on sex differences. Resources for Minority Health Month Throughout April, use these resources to promote the health of women from diverse cultural backgrounds. Visit FDA's Minority Health webpage.  Join OWH's Pink Ribbon Campaign and educate other women about mammograms. Download women's health materials in Spanish and 16 other languages. Check out the new FDA en Español webpage. Learn how FDA's Office of Minority Health and Office of Health and Constituent Affairs are addressing the impact of diabetes on minority communities. Extras Recall of Alli Weight Loss Products FDA is alerting consumers that GlaxoSmithKline (GSK) is withdrawing all lots of its weight loss product Alli from the U.S. market because some packages were tampered with and may contain other kinds of pills. GSK is voluntarily initiating this national market withdrawal to protect consumers from purchasing tampered product. Read the Safety Alert and View Product Images. Report a Serious Adverse Events Public Meeting on Pregnancy Registries FDA will be holding a public meeting on May 28 – 29, 2014 to obtain input to support the revision of guidance for industry on establishing pregnancy exposure registries. Register and Submit Comments FDA Meetings Risk Communication Advisory Committee - May 5-6, 2014   Public Meeting on Pulmonary Arterial Hypertension Patient-Focused Drug Development - May 13, 2014   OWH Conference Exhibits Women's Health 2014: 22nd Annual Congress - April 4-6   American College of Obstetricians and Gynecologists - April 26-30   Please share this update with your network, members, constituents, and community FDA Office of Women's Health 10903 New Hampshire Avenue WO32 - Room 2333 Silver Spring, MD 20993-0002 301-796-9440

---

Subscriber Services:
Manage Preferences  |  Unsubscribe  |  Help with this service

Stay Connected:

---

This email was sent to kostikblog@ukr.net using GovDelivery, on behalf of: U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 800-439-1420